
Security Check Required




FacebookJoin or Log Into Facebook   Email or PhonePasswordForgot account?Log InDo you want to join Facebook?Sign UpSign UpSecurity CheckPlease enter the text belowCan't read the text above?Try another text or an audio captchaText in the box:What's this?Security CheckThis is a standard security test that we use to prevent spammers from creating fake accounts and spamming users.SubmitEnglish (US)EspañolFrançais (France)中文(简体)العربيةPortuguês (Brasil)Italiano한국어Deutschहिन्दी日本語MessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook © 2017





DEPO Srinivas G. Rao Insider Trades for DepoMed Inc.


































Bulletin






Investor Alert







New York Markets After Hours



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































DepoMed Inc.

                  NASDAQ: DEPO
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

DepoMed Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:29 p.m.


DEPO

/quotes/zigman/63635/composite


$
10.31




Change

0.00
0.00%

Volume
Volume 20,945
Quotes are delayed by 20 min








/quotes/zigman/63635/composite
Today's close

$
			10.44
		


$
				10.31
			
Change

-0.13
-1.25%





Day low
Day high
$10.26
$10.55










52 week low
52 week high

            $9.38
        

            $27.02
        


















Insider Activity


Individual




Srinivas G. Rao



Dr. G. Srinivas Rao, MD PhD, is Chief Medical Officer & Senior Vice President at Depomed, Inc., a Member at American Pain Society, a Member at International Association for the Study of Pain, and a Member at Society For Neuroscience.
Dr. Srinivas Rao was previously employed as Executive VP & Head-Neuroscience Division by Retrophin, Inc., Chief Scientific Officer & Science Director by Cypress Bioscience, Inc., Chief Executive Officer by Kyalin Biosciences, Inc., and Chief Scientific Officer by Sova Pharmaceuticals, Inc.
He received his doctorate degree from the Yale School of Medicine and a doctorate degree from the Yale Graduate School of Arts & Sciences.



Transactions


Date
Shares
Transaction
Value





04/02/2017
940


 
Derivative/Non-derivative trans. at $12.55 per share.


11,797


12/01/2016
4,793


 
Derivative/Non-derivative trans. at $18.55 per share.


88,911


04/02/2016
940


 
Derivative/Non-derivative trans. at $14.38 per share.


13,518


03/08/2016
2,535


 
Derivative/Non-derivative trans. at $11.83 per share.


29,989


12/01/2015
1,645


 
Derivative/Non-derivative trans. at $19 per share.


31,255





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Arthur Joseph Higgins 
President, Chief Executive Officer & Director




Mr. August J. Moretti 
Chief Financial Officer & Senior Vice President




Dr. Srinivas G. Rao 
Chief Medical Officer & Senior Vice President




Dr. Gerd G. Kochendoerfer 
Senior Vice President-Technical Operations




Ms. Sharon D. Larkin 
Senior VP-Human Resources & Administration




Mr. Thadd M. Vargas 
Senior Vice President-Business Development




Mr. Peter W. Schineller 
Senior Vice President-Sales




Mr. Christopher S. Keenan 
VP-Investor Relations & Corporate Communications




Mr. Matthew M. Gosling 
Secretary, Senior Vice President & General Counsel




Dr. Shay  Bujanover 
Senior Director-Medical Affairs




Mr. James P. Fogarty 
Chairman




Mr. William T. McKee 
Independent Director




Mr. Gavin T. Molinelli 
Independent Director




Mr. Peter D. Staple 
Director




Mr. Louis J. Lavigne 
Independent Director




Ms. Karen A. Dawes 
Independent Director




Mr. Robert G. Savage 
Independent Director




Mr. James L. Tyree 
Independent Director
















Log In




5:13 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
5:12pWhat’s really happening with Target’s Cartwheel app
5:00pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
4:56pBREAKINGIn a tweet, Trump names Gen. Kelly his new chief of staff
4:56pMattel could get wrecked by weak ‘Cars 3’ toy sales
4:55pThis 1 number sums up why that Foxconn deal is over-the-top bad for Wisconsin
4:51pBREAKINGTrump tweets he's named a new chief of staff, John Kelly
4:42pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
4:34pLong-dated Treasury yields see weekly climb 
4:33pS&P 500, Nasdaq finish lower after Amazon disappointment; Dow closes at record
4:32pThe highest paid athletes in the world, in one chart
4:32pHow to raise your kids to be frugal (but not too frugal)
4:31pCities to move to if you want to work in tech — NOT including San Francisco
4:31pWhat Donald Trump’s battle of wills with Jeff Sessions teaches you about a difficult boss
4:31pOne way you’re paying credit-card fees, even if you don’t have a card
4:30pTrump, Russia and Sanctions: What We Know 
4:30pThis is the worst mistake people make at work
4:30pMove over, breathalyzers; ‘textalyzers’ could be used on drivers’ phones 
4:29pJared Kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere
4:28pHere’s how much you should spend on a yoga mat 
4:26p5 weird things I found out about America in my first 24 hours 
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Srinivas G. Rao | Management | Depomed





















Srinivas G. Rao, M.D., Ph.D.
Chief Medical Officer
Dr. Rao has extensive experience and background in pain and central nervous system diseases. He was the Founder and Chief Executive Officer of Kyalin Biosciences, a privately held biotechnology company developing a potential breakthrough therapy for autism, from its formation in 2011 through to its sale to Retrophin, Inc in 2013. In 2014, he served as Executive Vice President and Head of Neuroscience at Retrophin. From 2011 to 2013, Dr. Rao also served as CMO and CSO of 3 companies through his association with Avalon Ventures. Finally, from 2001 to 2011, he was Chief Scientific Officer of Cypress Bioscience where he had a broad range of responsibilities, from business to clinical development. He was the innovator behind Savella™, postulating that this drug's unique pharmacology would be effective for fibromyalgia. Savella™ was approved by the FDA for this indication in 2009.
Dr. Rao received his MD from Yale School of Medicine and his PhD in neurobiology from Yale Graduate School. Dr. Rao is a member of the American College of Neuropharmacology, the American Pain Society, International Association for the Study of Pain and the Society for Neuroscience.




About Us



Management


Arthur J. Higgins


Sharon D. Larkin


Matthew M. Gosling


August J. Moretti


Srinivas G. Rao


Thadd M. Vargas




Board of Directors


James P. Fogarty


Karen A. Dawes


Arthur J. Higgins


Louis J. Lavigne Jr.


William T. McKee


Gavin T. Molinelli


Robert G. Savage


Peter D. Staple


James L. Tyree




Compliance


Contact Us


Directions











Home


About Us


Products


Pipeline


Technology


Clinical Trials


Investors


Careers











Sitemap


Contact Us


A Growing Specialty Pharmaceutical Company





© Depomed, Inc.    All rights reserved



Terms of Use


Privacy Policy



Website design: Hane Chow Inc.

APL-DEP-0092 Rev. 3









Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft


















Srinivas G. Rao M.D. Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Srinivas G. Rao M.D. Ph.D.
Senior Vice President and Chief Medical Officer at Depomed, Inc.


View Full Profile
Are you Srinivas G. Rao M.D. Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Srinivas G. Rao M.D. Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Srinivas G. Rao M.D. Ph.D.'s  network and community.
												FOLLOW changes in Srinivas G. Rao M.D. Ph.D.'s employment and money-in-motion.
												CONNECT with Srinivas G. Rao M.D. Ph.D. through your network of contacts.
												








Srinivas G. Rao M.D. Ph.D.'s Executive Work History


Current


Senior Vice President and Chief Medical Officer, 
Depomed, Inc.


Past
To view Srinivas G. Rao M.D. Ph.D.'s complete executive work history, sign up now
Education


														 B.S., 
															Yale University


Age
48

 
 


Srinivas G. Rao M.D. Ph.D.'s Biography




			Srinivas G. Rao has served as Senior Vice President and Chief Medical Officer since July 2014. Prior to joining the Company in 2014, Dr. Rao served as Executive Vice President and Head of Neuroscience at Retrophin, Inc. From 2011 to 2013, Dr. Rao served as Founder and Chief Executive Officer of Kyalin Biosciences, Inc., a privately held biotechnology company he founded and that was acquired by Retrophin in 2013. From 2001 to 2011, Dr. Rao served as Chief Scientific Officer of Cypress Bioscience, Inc. Dr. Rao currently serves on the board of a privately-held company. Dr. Rao holds a M.D. and a Ph.D. from Yale University.
		
Source: Depomed, Inc. on 07/14/2017
		
	

 






Sign up for Equilar Atlas and view Srinivas G. Rao M.D. Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Srinivas G. Rao M.D. Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Srinivas G. Rao M.D. Ph.D.'s  network and community.
												FOLLOW changes in Srinivas G. Rao M.D. Ph.D.'s employment and money-in-motion.
												CONNECT with Srinivas G. Rao M.D. Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Srinivas G. Rao M.D. Ph.D.


















Srinivas G. Rao M.D. Ph.D.'s Connections (30)





Sign up now to view Srinivas G. Rao M.D. Ph.D.'s 30 connections »









Karen A. Dawes
Former Chairman of the Board, Repligen Corporation









James L. Tyree
Former Vice Chairman of the Board, Innoviva, Inc.









Louis J. Lavigne
Board Member, Accuray Incorporated









Tina S. Nova
Board Member, Arena Pharmaceuticals, Inc.









Thadd M. Vargas
Senior Vice President, Business Development, Depomed, Inc.









August J. Moretti
Chief Financial Officer and Senior Vice President, Depomed, Inc.









Vicente Anido
Chief Executive Officer and Chairman of the Board, Aerie Pharmaceuticals, Inc.









Peter D. Staple
Dir., President and Chief Executive Officer, Corium International, Inc.









James P. Fogarty
Board Member, Darden Restaurants, Inc.









Matthew M. Gosling
Senior Vice President and General Counsel, Depomed, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993


















Srinivas G. Rao Archives - MedWorks Media



















































 





 









                            Top Menu                        
About
Go To Store
Contact Us
Author Guidelines
Subscriptions
Digital Replica Editions
Login/Register
 


                            Main Menu                        
Home
Journals

Psychopharmacology Bulletin
T.E.N.
Mental Fitness
PSI
Oncology Spectrums


Projects - Monographs

JOURNAL SUPPLEMENTS
Pocket Reference Guides

English
Spanish


Physician Academy Series (PAS)
Teaching Monographs


Drugs A-Z
Brain Science Blogs
 









About
Go To Store
Contact Us
Author Guidelines
Subscriptions
Digital Replica Editions
Login/Register


0

Cart 









































Home›Products tagged “Srinivas G. Rao”








Srinivas G. Rao


	Showing all 2 results


Sort by popularity
Sort by average rating
Sort by newness
Sort by price: low to high
Sort by price: high to low







Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome
$30.00

Add to cart





Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective
$30.00

Add to cart










 
Please feel free to contact us with any questions
or inquiries.

Email: ceo@medworksmedia.com
Contact: 310.374.1300
Address: 2205 ROCKEFELLER LANE
                               BLDG B
                               REDONDO BEACH, CA • 90278

 

Subscribe NewsletterSubscribe To The MedWorks Media Mailing List For Updates









 

MedWorks Media Twitter Tweets by @jameslarossa


 





Home
Contact Us
About Us
IP Subscribers
Download Articles
Author Guidelines

© 1964-2017 Copyright MedWorksMedia. All rights reserved.Site Developed and Designed by Always Ahead CC




 
 









































Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome

































































 





 









                            Top Menu                        
About
Go To Store
Contact Us
Author Guidelines
Subscriptions
Digital Replica Editions
Login/Register
 


                            Main Menu                        
Home
Journals

Psychopharmacology Bulletin
T.E.N.
Mental Fitness
PSI
Oncology Spectrums


Projects - Monographs

JOURNAL SUPPLEMENTS
Pocket Reference Guides

English
Spanish


Physician Academy Series (PAS)
Teaching Monographs


Drugs A-Z
Brain Science Blogs
 









About
Go To Store
Contact Us
Author Guidelines
Subscriptions
Digital Replica Editions
Login/Register


0

Cart 









































Home›Psychopharmacology Bulletin›VOL 40 No. 4 Articles›Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome










 


Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome$30.00

FEATURE ARTICLE
Understanding The Fibromyalgia Syndrome
Srinivas G. Rao, MD, PhD, Judith F. Gendreau, MD, and Jay D. Kranzler, MD, PhD





Add to cart

Want a discount? Become a member by purchasing purchasing Psychopharmacology Bulletin Annual Subscription - Individual, Psychopharmacology Bulletin Annual Subscription - Institution, Psychopharmacology Bulletin Annual Subscription - In Training or MedWorks Media Site Wide Access Membership, or log in if you are a member.

Categories:Psychopharmacology Bulletin, VOL 40 No. 4 Articles 

Tags:chronic pain, controlled trials, dorsal horn, fibromyalgia, FMS, Jay D. Kranzler, Judith F. Gendreau, MD, neuroendocrine, pain, PhD, sleep, Srinivas G. Rao, syndrome, transporter binding 





Description


Reviews (0)



Description
Srinivas G. Rao, MD, PhD Link
FEATURE ARTICLE
Understanding The Fibromyalgia Syndrome
Srinivas G. Rao, MD, PhD, Judith F. Gendreau, MD, and Jay D. Kranzler, MD, PhD
PB-40-4-03-RAO
 




Reviews
There are no reviews yet.




Be the first to review “Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome” Cancel reply 
Your email address will not be published. Required fields are marked *Your rating
Rate…
Perfect
Good
Average
Not that bad
Very poor
Your review *Name * 
Email * 












 

 








Related products





Clozapine Related Suicidal Obsession by Branka Aukst-Margetic
$30.00

Add to cart





Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$30.00

Add to cart





Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology
$30.00

Add to cart





Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$30.00

Add to cart













 
Please feel free to contact us with any questions
or inquiries.

Email: ceo@medworksmedia.com
Contact: 310.374.1300
Address: 2205 ROCKEFELLER LANE
                               BLDG B
                               REDONDO BEACH, CA • 90278

 

Subscribe NewsletterSubscribe To The MedWorks Media Mailing List For Updates









 

MedWorks Media Twitter Tweets by @jameslarossa


 





Home
Contact Us
About Us
IP Subscribers
Download Articles
Author Guidelines

© 1964-2017 Copyright MedWorksMedia. All rights reserved.Site Developed and Designed by Always Ahead CC




 
 


















































